Skip to search boxSkip to navigationSkip to main content

Diabetic retinopathy and the NMDA receptor

  • Sylvia B. Smith(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Review article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Diabetic retinopathy is a major sight-threatening disease and is a leading cause of blindness. There is an emerging body of evidence that suggests that neuronal changes are an early phenomenon in the diabetic retina and that several cell types are affected, including the ganglion cells. The degeneration of these cells is thought to occur via overstimulation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor. Characteristic features of the normal mammalian retina and of the diabetic retina, and the involvement of NMDA receptors in diabetic retinopathy, are discussed.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 226-232 (7 pages)

Journal (Volume, Issue Number)

Drug News and Perspectives (Volume 15, Issue 4)

Publication milestones

  • Published - 2002

Publication status

Published - 2002

ISSN

0214-0934

Publication IDs

  • Scopus: 0036087824

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
0.30
SciVal
Author count
1
SciVal
citations
20
SciVal
Paper percentile
70
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
46
Citation count
37